A killed vaccine, also called an inactivated vaccine, is made from a virus or bacterium that has been grown in a lab and then destroyed so it can no longer reproduce or cause disease. The dead pathogen still looks enough like the real thing to train your immune system to recognize and fight it. Several widely used vaccines work this way, including shots for polio, hepatitis A, rabies, and the flu.
How the Pathogen Is Killed
Making a killed vaccine starts with growing large quantities of the actual disease-causing germ. Viruses are typically cultivated on living cells. Hepatitis A virus, for example, is grown on a line of human cells called MRC-5. The poliovirus used in the injectable Salk vaccine is grown on monkey kidney cells. Influenza virus is propagated inside embryonated chicken eggs. Bacteria destined for inactivated vaccines are grown in bioreactors using nutrient-rich media designed to maximize yield.
Once enough pathogen has been produced, it needs to be killed without destroying the surface structures that your immune system needs to learn from. The two chemicals used in virtually all licensed human killed vaccines are formaldehyde and a compound called beta-propiolactone (BPL). Formaldehyde is the more common of the two. It works by chemically cross-linking proteins in the pathogen, locking its structure in place so the germ can never replicate again. Other methods exist in research settings, including hydrogen peroxide treatment, gamma irradiation, UV light, and heat, but these haven’t made it into routine human vaccines.
After inactivation, the vaccine is purified. For hepatitis A vaccine, that means filtering and running the material through a chromatography column to separate the viral particles from leftover cell debris. For the flu vaccine, the process involves centrifugation on a sucrose gradient followed by additional chemical purification. The goal is a clean preparation of dead pathogen, free of contaminants, ready to be formulated into a final product.
How Killed Vaccines Train Your Immune System
When you receive a killed vaccine, your immune system encounters the dead pathogen’s surface proteins and treats them as foreign invaders. This triggers your body to produce antibodies, the proteins that tag and neutralize germs. The response is driven primarily by a type of white blood cell called a CD4+ T cell, which coordinates the production of those antibodies. CD8+ T cells, which are responsible for directly destroying infected cells, play a smaller role with killed vaccines.
One advantage of killed vaccines over newer targeted vaccines (like mRNA shots that focus on a single protein) is that they contain the whole pathogen, surface and all. That means your immune system sees multiple proteins at once, potentially building a broader range of defenses. Research on inactivated COVID-19 vaccines, for instance, showed they generated immune responses against several viral proteins, not just the spike protein targeted by mRNA vaccines.
The trade-off is that the immune response tends to be weaker and shorter-lived than what you get from a live vaccine. Because the pathogen is dead, it doesn’t replicate inside your body the way a weakened live virus would. That means less stimulation of the immune system overall. This is why killed vaccines almost always require multiple doses and periodic boosters to build and maintain protection.
Why Boosters and Adjuvants Are Needed
Most killed vaccines require a primary series of two or more shots, followed by boosters at regular intervals. The hepatitis A vaccine is given in two doses. The inactivated polio vaccine requires four doses during childhood. The flu shot is reformulated and given every year because the virus mutates, but even setting mutations aside, the immunity from an inactivated flu vaccine fades within months.
To compensate for the weaker immune stimulation, many killed vaccines include an adjuvant, an added ingredient that amplifies your body’s response. Aluminum-based adjuvants are the most common type and have been used in vaccines since the 1930s. They come in several forms, including aluminum hydroxide and aluminum phosphate. These adjuvants essentially act as an alarm signal, drawing more immune cells to the injection site and keeping the antigen available longer so your body has more time to learn from it. Newer adjuvants are being developed to target specific parts of the immune response for stronger, longer-lasting protection.
Common Killed Vaccines
Several vaccines on the standard U.S. immunization schedule and travel vaccine list are killed vaccines:
- Polio (IPV): The injected Salk vaccine, used in the U.S. and most high-income countries. Made from all three types of poliovirus, grown on cells, then inactivated with formaldehyde.
- Hepatitis A: Available as Havrix or VAQTA. The virus is grown on human cells, then killed with formalin.
- Rabies: Given after potential exposure to rabid animals, or preventively for people at high risk like veterinarians. Available as Imovax and RabAvert.
- Flu (injectable): The standard flu shot is an inactivated vaccine. The nasal spray version is a different type (live attenuated).
- Japanese encephalitis: Ixiaro, recommended for travelers to parts of Asia.
Safety for Immunocompromised People
One of the biggest practical advantages of killed vaccines is their safety profile for people with weakened immune systems. Because the pathogen is dead, there is zero risk of it causing the disease it was designed to prevent. The CDC states that all non-live vaccines, including killed whole-organism vaccines, can be safely given to immunocompromised individuals.
This stands in sharp contrast to live vaccines. People with compromised immunity from conditions like HIV, organ transplants, or chemotherapy are generally advised to avoid live vaccines such as MMR (measles, mumps, rubella), oral polio, varicella (chickenpox), and yellow fever. Severe complications have been documented when immunocompromised patients received these live vaccines, because the weakened pathogen can sometimes cause real disease in someone whose immune system can’t keep it in check. Killed vaccines carry no such risk.
The Polio Example: Killed vs. Live
Polio offers the clearest real-world comparison between a killed and a live vaccine. Jonas Salk’s killed vaccine (IPV), introduced in the 1950s, is given by injection. Albert Sabin’s live attenuated vaccine (OPV) is given as oral drops. Both have been instrumental in reducing polio cases by more than 99% worldwide, but they work differently and carry different risks.
IPV produces excellent protection against paralytic polio. However, it is less effective at preventing the virus from living in your gut and being shed in your stool, which means vaccinated people can still unknowingly spread the virus. OPV, because it mimics a natural gut infection, does a better job of blocking transmission entirely. That made OPV the workhorse of global eradication campaigns in developing countries, where person-to-person spread was the main concern.
The catch is that OPV uses a live, weakened virus that can, in rare cases, mutate back into a form capable of causing paralysis. This is why many countries, including the U.S. and the UK, switched entirely to the killed IPV. The eradication effort now needs both: OPV to stop transmission in the remaining endemic areas, and IPV to protect individuals safely everywhere else.
Storage Requirements
Killed vaccines are generally straightforward to store. Most need standard refrigeration between 2°C and 8°C (36°F to 46°F), the same temperature range as a home refrigerator. This applies to hepatitis A, hepatitis B, IPV, and the flu shot. The critical rule for aluminum-adjuvanted killed vaccines is that they must never be frozen. Freezing permanently damages the aluminum adjuvant, destroying the vaccine’s effectiveness.
Live vaccines can be more demanding. Varicella and MMRV vaccines must be stored frozen, between -50°C and -15°C. Single-component varicella vaccine has to be discarded just 72 hours after being moved to a refrigerator. These stricter requirements make live vaccines harder to distribute in places without reliable cold chain infrastructure, giving killed vaccines a logistical advantage in many settings.